ERIC TROYER: Open Payments
NPI 1962409748 · LANDIS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 25 payments from 10 companies in 2025. Trend: 2023 $506 · 2024 $344 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $121 |
| ABBVIE INC. | 5 | $106 |
| Braeburn Inc. | 5 | $92 |
| Gilead Sciences, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| Novo Nordisk Inc | 2 | $33 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $20 |
| Ardelyx, Inc. | 1 | $18 |
| TOLMAR, INC. | 1 | $17 |
| Orexo US, Inc. | 1 | $16 |
Products named: SUBLOCADE, BRIXADI, MAVYRET, UBRELVY, QULIPTA, MOUNJARO, ZEPBOUND, Quviviq.
Industry payments across NC — which companies pay providers there.
